Company intelligence / Profile preview

Congela Biocosmetics

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

Congela Biocosmetics commercializes JuveXO, a topical exosome-based cosmetic serum for skin and hair appearance, and XO Spray, an oxygen-infusion device that delivers JuveXO and other serums; products are marketed to aesthetic practitioners and consumers, with claims focused on cosmetic rejuvenation rather than therapeutic disease treatment.

Therapeutic areas: Dermatology
Modalities: BiologicExosome-based therapyDevice
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Congela Biocosmetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Congela Biocosmetics.

Explore the full profile